Free Trial

Rayonier (RYN) Competitors

Rayonier logo
$27.85 +0.27 (+0.99%)
Closing price 03:59 PM Eastern
Extended Trading
$27.84 -0.01 (-0.04%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RYN vs. OHI, CUBE, HR, RHP, SBRA, EPR, GEO, MPW, PCH, and NHI

Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), Sabra Health Care REIT (SBRA), EPR Properties (EPR), The GEO Group (GEO), Medical Properties Trust (MPW), PotlatchDeltic (PCH), and National Health Investors (NHI). These companies are all part of the "specialized reits" industry.

Rayonier vs.

Omega Healthcare Investors (NYSE:OHI) and Rayonier (NYSE:RYN) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Omega Healthcare Investors has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Rayonier has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.

Omega Healthcare Investors received 143 more outperform votes than Rayonier when rated by MarketBeat users. Likewise, 57.77% of users gave Omega Healthcare Investors an outperform vote while only 54.40% of users gave Rayonier an outperform vote.

CompanyUnderperformOutperform
Omega Healthcare InvestorsOutperform Votes
446
57.77%
Underperform Votes
326
42.23%
RayonierOutperform Votes
303
54.40%
Underperform Votes
254
45.60%

Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.2%. Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 3.9%. Omega Healthcare Investors pays out 172.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 46.2% of its earnings in the form of a dividend.

Omega Healthcare Investors has higher earnings, but lower revenue than Rayonier. Rayonier is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Healthcare Investors$1.05B10.02$406.33M$1.5524.13
Rayonier$1.26B3.41$359.10M$2.3611.70

65.3% of Omega Healthcare Investors shares are owned by institutional investors. Comparatively, 89.1% of Rayonier shares are owned by institutional investors. 1.4% of Omega Healthcare Investors shares are owned by insiders. Comparatively, 0.8% of Rayonier shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Omega Healthcare Investors has a net margin of 38.65% compared to Rayonier's net margin of 28.44%. Omega Healthcare Investors' return on equity of 9.71% beat Rayonier's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Healthcare Investors38.65% 9.71% 4.35%
Rayonier 28.44%3.86%1.99%

Omega Healthcare Investors currently has a consensus price target of $42.25, indicating a potential upside of 12.98%. Rayonier has a consensus price target of $29.00, indicating a potential upside of 5.05%. Given Omega Healthcare Investors' stronger consensus rating and higher probable upside, analysts plainly believe Omega Healthcare Investors is more favorable than Rayonier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Healthcare Investors
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44
Rayonier
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, Omega Healthcare Investors had 8 more articles in the media than Rayonier. MarketBeat recorded 10 mentions for Omega Healthcare Investors and 2 mentions for Rayonier. Rayonier's average media sentiment score of 1.29 beat Omega Healthcare Investors' score of 1.23 indicating that Rayonier is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omega Healthcare Investors
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rayonier
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Omega Healthcare Investors beats Rayonier on 14 of the 19 factors compared between the two stocks.

Remove Ads
Get Rayonier News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYN vs. The Competition

MetricRayonierReal estate investment trusts IndustryConstruction SectorNYSE Exchange
Market Cap$4.31B$7.00B$8.17B$19.55B
Dividend Yield3.88%6.56%2.03%3.75%
P/E Ratio11.7062.6915.8233.49
Price / Sales3.416.8468.0528.58
Price / Cash18.5417.3221.4017.54
Price / Book2.311.714.254.56
Net Income$359.10M$177.71M$535.55M$1.02B
7 Day Performance-0.90%-1.05%-0.51%-0.36%
1 Month Performance5.91%-1.78%-2.04%-3.42%
1 Year Performance-16.80%6.38%14.32%5.93%

Rayonier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYN
Rayonier
3.4765 of 5 stars
$27.85
+1.0%
$29.00
+4.1%
-16.8%$4.35B$1.26B11.80420Positive News
OHI
Omega Healthcare Investors
3.5051 of 5 stars
$38.27
+1.7%
$41.44
+8.3%
+20.7%$10.79B$1.05B24.7050Positive News
CUBE
CubeSmart
3.7487 of 5 stars
$42.12
+1.1%
$48.00
+14.0%
-5.0%$9.60B$1.07B23.813,040
HR
Healthcare Realty Trust
2.1748 of 5 stars
$16.77
+0.8%
$17.00
+1.4%
+24.6%$5.87B$1.25B-9.40580Positive News
RHP
Ryman Hospitality Properties
4.1683 of 5 stars
$97.67
+1.1%
$125.67
+28.7%
-19.1%$5.85B$2.34B22.241,471Analyst Forecast
SBRA
Sabra Health Care REIT
3.0649 of 5 stars
$17.62
+1.8%
$19.17
+8.8%
+20.9%$4.19B$703.24M33.2240Positive News
EPR
EPR Properties
3.3388 of 5 stars
$51.86
+0.3%
$50.13
-3.3%
+24.0%$3.95B$641.00M22.4660Analyst Forecast
GEO
The GEO Group
3.2048 of 5 stars
$26.07
-2.1%
$32.75
+25.6%
+93.1%$3.67B$2.42B90.2215,800Analyst Forecast
Options Volume
MPW
Medical Properties Trust
3.4512 of 5 stars
$6.04
+2.8%
$5.64
-6.5%
+46.2%$3.63B$995.55M-1.43120Positive News
PCH
PotlatchDeltic
3.4222 of 5 stars
$45.77
+1.7%
$48.71
+6.4%
-3.8%$3.61B$1.06B163.681,383News Coverage
Positive News
NHI
National Health Investors
3.5031 of 5 stars
$75.41
+0.4%
$84.50
+12.1%
+19.9%$3.45B$335.18M25.9320
Remove Ads

Related Companies and Tools


This page (NYSE:RYN) was last updated on 3/24/2025 by MarketBeat.com Staff
From Our Partners